In vitro effects of azithromycin on Salmonella typhi:: early inhibition by concentrations less than the MIC and reduction of MIC by alkaline pH and small inocula

被引:25
作者
Butler, T [1 ]
Frenck, RW
Johnson, RB
Khakhria, R
机构
[1] Texas Tech Univ, Hlth Sci Ctr, Dept Internal Med, Lubbock, TX 79430 USA
[2] USN, Med Res Unit 3, Dept Clin Invest, FPO, AE 09835 USA
[3] Pfizer Inc, Div Cent Res, Groton, CT 06340 USA
[4] Bur Microbiol, Ottawa, ON KIA 0L2, Canada
关键词
D O I
10.1093/jac/47.4.455
中图分类号
R51 [传染病];
学科分类号
100401 [流行病与卫生统计学];
摘要
To explain good clinical results of azithromycin in patients with typhoid fever, 10 strains of Salmonella typhi were grown in cation-adjusted Mueller-Hinton broth. MICs of azithromycin were 4-16 mg/L. At a sub-MIC of 2 mg/L, early inhibition of growth was shown at 2, 4 and 8 h of incubation, but at 24 and 48 h growth to turbidity occurred. At 4 mg/L, inhibition occurred up to 8 h, after which growth towards turbidity followed. Elongated curved bacilli formed in broth containing 4 mg/L after 24-48 h. Adjusting the pH of the broth with phosphate-citrate buffer to 7.5 and 8.0 caused reductions in MICs to 0.25-0.5 mg/L. Large inocula of 10(6) cfu/mL resulted in median MICs four- to six-fold greater than with inocula of 10(1)-10(3) cfu/mL. An inoculum of 10 bacteria per mt in broth at pH 7.5 resulted in an MIC of 0.13 mg/L. Clinical benefits in patients may occur because of early inhibition by sub-MIC concentrations of azithromycin, and due to lower MICs at alkaline pH and lower MICs with small inocula that may correspond to the low-grade bacteraemia in typhoid fever.
引用
收藏
页码:455 / 458
页数:4
相关论文
共 9 条
[1]
TYPHOID-FEVER - STUDIES OF BLOOD-COAGULATION, BACTEREMIA, AND ENDOTOXEMIA [J].
BUTLER, T ;
BELL, WR ;
LEVIN, J ;
LINH, NN ;
ARNOLD, K .
ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (03) :407-410
[2]
Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India [J].
Butler, T ;
Sridhar, CB ;
Daga, MK ;
Pathak, K ;
Pandit, RB ;
Khakhria, R ;
Potkar, CN ;
Zelasky, MT ;
Johnson, RB .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (02) :243-250
[3]
Pharmacodynamics of macrolides, azalides, and streptogramins: Effect on extracellular pathogens [J].
Carbon, C .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (01) :28-32
[4]
Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance [J].
Girgis, NI ;
Butler, T ;
Frenck, RW ;
Sultan, Y ;
Brown, FM ;
Tribble, D ;
Khakhria, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (06) :1441-1444
[5]
INVITRO ACTIVITY OF AZITHROMYCIN COMPARED WITH OTHER MACROLIDES AND ORAL ANTIBIOTICS AGAINST SALMONELLA-TYPHI [J].
METCHOCK, B .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1990, 25 :29-31
[6]
National Committee for Clinical Laboratory Standards, 1997, M7A4 NCCLS
[7]
SPECTRUM AND MODE OF ACTION OF AZITHROMYCIN (CP-62,993), A NEW 15-MEMBERED-RING MACROLIDE WITH IMPROVED POTENCY AGAINST GRAM-NEGATIVE ORGANISMS [J].
RETSEMA, J ;
GIRARD, A ;
SCHELKLY, W ;
MANOUSOS, M ;
ANDERSON, M ;
BRIGHT, G ;
BOROVOY, R ;
BRENNAN, L ;
MASON, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1987, 31 (12) :1939-1947
[8]
Quantitation of bacteria in blood of typhoid fever patients and relationship between counts and clinical features, transmissibility, and antibiotic resistance [J].
Wain, J ;
Diep, TS ;
Ho, VA ;
Walsh, AM ;
Hoa, NTT ;
Parry, CM ;
White, NJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (06) :1683-1687
[9]
Uptake of azithromycin by various cells and its intracellular activity under in vivo conditions [J].
Wildfeuer, A ;
Laufen, H ;
Zimmermann, T .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) :75-79